Home » Pfizer’s Catalyst Earns Microsoft’s Praise
Pfizer’s Catalyst Earns Microsoft’s Praise
PharmaManufacturing.com
07/28/2006
By Paul Thomas
Pfizer received Microsoft’s second annual Pharmaceutical and Life Sciences Innovation Awards, in the manufacturing category, for its Catalyst solution.
Catalyst, developed at Pfizer’s Groton facility over the past several years, is a suite of tools that help engineers to automate API process design, analysis and production planning. It is enabled by Microsoft’s .NET platform, and also relies upon the SQL Server and SharePoint Portal Server. Catalyst allows API process engineers to do critical aspects of their work via a web-based, graphical user interface systems.
As is well known in the industry, process development is often hampered by engineers’ inability to track down critical data, or to transfer that data from site to site to capitalize on a company’s collective intellect. One inevitable result is slower time to market. A team of Pfizer’s Groton engineers met this challenge head on, and set out to reduce the time and effort of finding data and preparing documents, and to find a way to provide useful real-time information that could be shared broadly. The Pfizer team consulted with Microsoft and the two parties initiated the Catalyst project.
The design function of Catalyst provides engineers with stored recipe models, to which information about process materials, equipment, reactions and other key factors is added to generate immediate production recipes.
The planning function allows Catalyst to adapt recipes for other plants based on the unique characteristics of those facilities. It is also used to identify production areas and equipment that may be available and suitable for certain API processes. This could allow Pfizer to better divide production responsibilities between its 12 API plants throughout the world.
The analytical component of Catalyst can be used primarily to readily assess production and, if all is well, generate electronic records for FDA compliance. Should analysis identify a problem with a batch, it can greatly facilitate investigation by putting key production information at the fingertips of the company’s best engineers, regardless of where they are located.
More News:
- 09/02/2010 SEC Nabs Merck Exec for Insider TradingFrom NYPost.com
- 09/02/2010 PBS: Behind FDA's Resource ChallengeFrom PBS.org
- 08/30/2010 Sanofi CEO: Genzyme is 'Stonewalling'From TheStreet.com
- 08/26/2010 115 Employees at Pfizer Will Lose Jobs in DecemberFrom RecordOnline.com
- 08/26/2010 Mexican Drug Gangs Target Pharma ShipmentsFrom SecuringPharma.com
- 08/26/2010 Lilly Manufacturing Facility Shutting Down, 140 People AffectedFrom MyCentralJersey.com
- 08/25/2010 Rockwell Automation Releases FactoryTalk Pharma Suite 2.1 Software
- 08/24/2010 Recall Fallout: FDA Puts Execs On NoticeFrom Money.CNN.com
- 08/19/2010 Dumped in a Parking Lot: How Pfizer Fires Sales Reps It Doesn't LikeFrom BNet.com
- 08/19/2010 Pharma's Contraction Leads to Outsourcing HiresFrom Portfolio.com
- All news »
Get Connected Now!
- Featured White Papers

Print page